Bolt Biotherapeutics's total assets for Q4 2025 were $56.75M, a decrease of -12.77% from the previous quarter. BOLT total liabilities were $30.24M for the fiscal quarter, a -8.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.